Clinical Trial Update: A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant [NA]

View source ↗

Summary

A feasibility study evaluating CLINIMACS for alpha/beta T-cell depletion in stem cell transplantation to reduce graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Christopher Dvorak | Conditions: Graft Vs Host Disease, Graft-versus-host-disease | NA | Status: RECRUITING